报告人：Paras N.Prasad 教授
Institute for Lasers, Photonics and Biophotonics
Departments of Chemistry, Physics, Electrical Engineering and Medicine
State University of New York at Buffalo, Buffalo, New York 14260
时 间：2023年12月5日（周二）9:30
地 点：深圳大学粤海校区光电子研究所三楼多功能厅
Short Bio of Paras N. Prasad
PRASAD currently holds the unique multidisciplinary position of SUNY Distinguished Professor of Chemistry, Physics, Electrical Engineering, and Medicine (four departments spanning three schools). He is the Samuel P. Capen Chair of Chemistry and the Executive Director of the multidisciplinary Institute for Lasers, Photonics and Biophotonics, which he founded in 1999. His pioneering contributions in interdisciplinary research at the interface of photonics, nanotechnology, and biomedicine have broadly impacted healthcare, energy, and optical technologies.
Scientific American named him among the world’s top 50 science and technology leaders. He has authored ~900 scientific papers; four field-defining monographs, widely used in teaching worldwide, in nonlinear optics, biophotonics, nanophotonics, and nanomedicine; eight edited books; and numerous patents. He introduced and advanced new frontiers of organic nonlinear optics, nanophotonics, biophotonics and nanomedicine. His Google Scholar h-Index is 136 , with ~84,000 citations . He was awarded the highly prestigious VAJRA Distinguished Professorship of Department of Science and Technology of Government of India at IIT at Delhi , India( 2022).
His many awards for research excellence include 2021 IEEE Photonics Society William Streifer Scientific Achievement Award ; IEEE Pioneer Award in Nanotechnology; the American Chemical Society Peter Debye Award , the Morley Medal and the Schoellkopf Medal; SPIE’s highest honor of Gold medal; Optical Society Michael Feld Biophotonics award; Western New York Health Care Industries Technology/Discovery Award; SUNY Excellence in the Pursuit of Knowledge award; UB’s first Innovation Impact award; UB President’s Medal; , Guggenheim Fellowship; Sloan Fellowship .
He is an elected foreign fellow of the National Academy of Sciences, India and Brazilian Academy of Sciences . He is a fellow of the National Academy of inventors . He is a fellow of the APS, OSA, SPIE, and IEEE and was listed among Thompson Reuters “Highly Cited Researchers” for 2014 &2016. He has Honorary Doctorates from KTH in Sweden, the Aix-Marseille University in France, MEPhI in Russia, and the Federal University of Pernambuco in Brazil. Globally, his technologies have produced nine 9 spin-off companies, including publicly-traded Nanobiotix, now in advanced clinical trials for cancer therapy.
Report Abstract
Major breakthroughs needed to meet 21st Century technical challenges across areas of top global priority such as healthcare will be achieved through convergence of science. This talk will provides examples of how our institute is using convergence of science linking materials science with nanotechnology , photonics and Biology to advance biophotonics and nanomedicine for theranostics .
In Biophotooincs , we are developing cellular diagnostics using Ramanomics , nonlinear optical and photoacoustic imaging and photon upconversion in nanostructures aimed towards early detection of diseases . Ramanomics involves quantitative confocal micro-Raman spectroscopic detection and multivariate analysis . We have coupled this with a proprietary Biomolecular Composition Analysis (BCA) software for noninvasive subcellular biochemical analysis in live cells in situ. In an integrated biophotonics program , we are using nonlinear optical imaging such as CARS and third harmonic generation to probe subcellular structure and dynamics . Through Nanophotonics , we are developing photon conversion science and technology using hybrid nanostructures and 2-D materials , and their heterostructures for efficient transformation of photons to biologically useful spectral regions . Another major direction being pursued in our lab, is neurophotonics, where we apply photoresponsive materials for sensing and functional mapping of the brain using optical and photoacoustic imaging.
In an extension to Nanobiophotonics ,our research involves nanoparticles for targeted and optically guided and optically activated combined diagnostic and therapy , also termed as theranostic . Here, our program is focusing on Alzheimer, traumatic brain injury (TBI) and glioblastoma (brain cancer) in addition to infectious diseases and other cancer . We are using targeted nanoparticles, capable of crossing the blood-brain barrier (BBB) and delivering IR emitting imaging probes as well as therapeutic optogenetic, and microglia stimulating agents .
1. P.N. Prasad “Introduction to Biophotonics ”, John Wiley & Sons, New York (2003).
2. P.N. Prasad “Introduction to Nanomedicine and Nanobioengineering” Wiley (2012)
